B-CELL LYMPHOMA REFRACTORY
Clinical trials for B-CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA CAR-T therapy targets tough blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with B-cell lymphoma or leukemia that has returned or not responded to standard therapy. The treatment uses special particles to deliver mRNA into the body to create CAR-T cells that target two markers on cancer cells. The goal is to se…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE2 • Sponsor: Daihong Liu • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Supercharged immune cells take on tough blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized therapy where a patient's own immune cells are genetically modified to recognize and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have not responded to standard treatment…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New CAR T-Cell therapy targets tough lymphoma
Disease control Recruiting nowThis study tests a new type of CAR T-cell therapy for people with B-cell lymphoma that has come back or not responded to other treatments. The therapy uses a patient's own immune cells, modified to attack cancer cells. The goal is to find the best dose and see if it is safe and e…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for hard-to-treat brain lymphoma: drug combo trial opens
Disease control Recruiting nowThis study tests a new drug, selinexor, combined with standard chemotherapy for people with a type of B-cell lymphoma that has come back or not responded to treatment and has spread to the brain or spinal cord. The goal is to find the best dose and see if the combination helps sh…
Matched conditions: B-CELL LYMPHOMA REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 20, 2026 11:56 UTC